TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
RVTY

Revvity Inc.

Healthcare · Diagnostics & Research

143.50$ -2.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement RVTY
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
56.6% 55.8% 54.0% 54.4% 55.0% 55.2% 47.4% 40.4% 46.8% 51.9% 52.0% 46.9%
43.4% 44.2% 46.0% 45.6% 45.0% 44.8% 52.6% 59.6% 53.2% 48.1% 48.0% 53.1%
5.4% 5.3% 5.9% 6.2% 6.7% 6.6% 5.4% 5.2% 6.7% 7.9% 7.1% 7.6%
28.3% 24.3% 32.1% 31.0% 36.9% 36.1% 34.7%
33.1% 31.5% 31.5% 32.1% 31.7% 30.8% 25.7% 24.6% 29.6% 33.5% 33.1% 40.6%
10.3% 12.7% 14.4% 13.5% 13.4% 14.1% 27.0% 35.0% 23.6% 14.5% 14.9% 12.5%
1.6% 1.8% 2.0% 1.9% 2.4% 2.2% 1.3% 2.7% 3.1% 3.6% 3.5% 3.2%
7.6% 9.9% 11.5% 13.1% 9.3% 8.2% 24.0% 31.4% 19.7% 6.7% 11.5% 9.4%
0.4% 1.0% 1.3% 6.2% 0.7% 0.3% 4.7% 8.2% 4.2% 0.1% 1.2% 0.9%
7.1% 10.1% 11.0% 5.0% 8.6% 7.9% 19.2% 24.6% 17.2% -4.3% 10.7% 8.5%
14.4% 16.7% 18.2% 19.7% 18.2% 17.9% 31.8% 42.2% 35.7% 25.9% 30.5% 23.2%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?